BSEBoard Meeting21 Oct 2026 · 21 Oct 2026, 01:17 pm
We wish to inform you that pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, a meeting of Board of Directors of the Company was held on Wednesday, October 21, 2026, through Video Conferencing ('VC'), The meeting commenced at 12.00 noon and interalia the following decisions were taken: 1. Adoption of Unaudited Financial Results for (Q2) quarter ....
Morarka Finance Ltd · 511549
✦ AI SummaryResults
Morarka Finance Ltd has announced its unaudited financial results for the Q2 and half year ended September 30, 2026, with the company's management and board of directors approving the results.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Morarka Finance Ltd - 511549 - Board Meeting Outcome for Regulation 30 - Outcome Of Board Meeting (Schedule III Part A - (4))
Attachments (1)
📄pdf
Download →
33e319e1-5475-49e1-9d38-a4a699dceef1.pdf
View document text
MORARKA FINANCE LIMITED
Regd.Office : 511, Maker Chambers V, 221, Nariman Point, Mumbai - 400 021. Tel. : 22832468, 22042945 Fax : 2204 7288
www.morarkafinance.in , investors@morarkafinance.in
CIN: L67120MH1985PLC035632
REF: MFL/2026-27 /098 October 21, 2026
Corporate Relationship Department
BSE Limited
1st Floor, New Trading Ring
Rotunda Building, P.J. Towers
Dalal Street, Fort
Mumbai - 400 001
Scrip Code - 511549
Sub: Regulation 30 - Outcome of Board Meeting (Schedule III Part A - ( 4))
Dear Sir,
We wish to inform you that pursuant to Regulation 30 (read with Part A of Schedule III) and
Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, a meeting
of Board of Directors of the Company was held on Wednesday, October 21, 2026, through Video
Conferencing ("VC"), The meeting commenced at 12.00 noon and interalia the following decisions
were taken:
1. Adoption of Unaudited Financial Results for (Q2) quarter and half year ended September 30,
2026, together with the Statement of Assets & Liabilities, Cash Flow Statement, and Limited
Review Report as received from the Statutory Auditors.
The meeting was concluded at 1.15 p.m.
You are kindly requested to take the same on record.
Thanking you;
Yours Sincerely
Divya Agarwal
Company Secretary & Compliance officer
MORARKA FINANCE LIMITED
Regd.Office : 511, Maker Chambers V, 221, Nariman Point, Mumbai - 400 021. Tel. : 22832468, 22042945 Fax : 2204 7288
www.morarkafinance.in , investors@morarkafinance.in
CIN: L67120MH1985PLC035632
REF: MFL/2026-27 /099 October 21, 2026
Corporate Relationship Department
BSE Limited
1st Floor, New Trading Ring
Rotunda Building, P.J. Towers
Dalal Street, Fort
Mumbai - 400 001
Scrip Code - 511549
Sub: Reg,ulation 33(3)(a) - Financial Results
Dear Sir,
Pursuant to Regulation 33(3)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, enclosed please find duly approved Unaudited Financial Result as per IND AS for (Q2) quarter and
half year ended September 30, 2026, along with statement of Assets & liabilities, Cash Flow and Limited
Review Report received from our Statutory Auditors M/s. Jayesh Dadia & Associates LLP, in the meeting
of Board of Directors of the Company held on Wednesday, October 21, 2026.
Kindly acknowledge the receipt and take the same on record.
Thanking you,
Yours Sincerely
Divya Agarwal
Company Secretary & Compliance officer
JAYESH DADIA & ASSOCIATES LLP
CHARTERED ACCOUNT ANTS
422, Arun Chambers, Tardeo, Mumbai - 400034. Tel.: +91-22-66602417 / 66601056 Fax: +91-22-66602418
E-mail: info@jdaca.com Website: www.jdaca.com
Independent Auditors Review Report on unaudited quarterly and half yearly financial
results of Morarka Finance Limited ended on September 30, 2026 pursuant to the
Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Reguhttions,
2015, (as amended)
The Board of Directors of
Morarka Finance Limited
511, Maker Chamber V,
221, Nariman Point,
Mumbai - 400 021
Introduction
We have reviewed the accompanying statement of unaudited financial results ('the
statement') of Morarka Finance Limited ('the Company') for the quarter and half year
ended September 30, 2026, attached herewith, being submitted by the Company pursuant to
the requirements of Regulation 33 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (the "Listing Regulations"), as amended.
This statement, which is the responsibility of the company's management and has been
approved by the Board of Directors, has been prepared in accordance with the recognition
and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial
Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013. and
other accounting principles generally accepted in India and in compliance with Regulation
33 of the Listing Regulations. Our responsibility is to issue a report on the statement based
on our review.
Scope of Review
We conducted our review in accordance with the Standard on Review Engagement (SRE)
2410, 'Review of Interim Financial Information performed by the Independent Auditor of
the Entity' issued by the Institute of Chartered Accountants of India. This standard requires
that we plan and perform the review to obtain moderate assurance as to whether the
statements are free of material misstatement. A review is limited primarily to inquiries of
company personnel and analytical procedures applied to financial data and thus provide less
assurance than an audit. We have not performed an audit and accordingly, we do not express
an audit opinion.
Conclusion
Based on our review conducted as above. nothing has come to our attention that causes us to
believe that the accompanying statement, prepared in accordance with applicable Indian
accounting standards (IND AS) specified under Section 133 of the Companies Act, 2013 as
amended, read with relevant rules issued thereunder and other recognized accounting
practices and policies has not disclosed the information required to be disclosed in terms of
Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations.
2015 and SEBI circular(s) including the manner in which it is to be disclosed. or that it
contains any material misstatement.
Samir Jaijinendra Shah
Place - Mumbai
Date - 21st October, 2026
'. ,
.,, t 1
MORARKA FINANCE LIMITED
Registered Office: 511, Maker Chambers v, 221, Nariman Point, Mumbai - 400 021
Tel: +91 022 22832468
CIN. L67120MH1985PlC035632, Email: investors@morarkafinance.in, Website : www.morarkafinance.in
,. ,,.., . ..
I I I • r,c,11 11011•11 : '
rlf in
Quarter Ended Six Months Ended Year Ended
September June September September September March
SI. Particulars 30, 2026 30, 2026 30, 2025 30, 2026 30, 2025 31, 2026
(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited)
I Income
Revenue from operations
(i) Interest income 0.23 0.02 7.53 0.25 8.25 9.09
(ii) Dividend income 22.48 29.44 135.81 51.92 136.83 137.21
(iii) Rental income 3.88 3.87 3.88 7.75 7.75 15.50
(iv) Fees and commision income 9.75 9.75 9.75 19.50 19.50 39.00
(v) Net gain on fair value change (1.97) 14.82 4.41 12.85 18.28 15.85
(vi) Net gain on derecognition of financial instruments under
amortised cost
4.25
(vii) Sale of products
(viii) Sale of services 0.28 0.28 0.26 0.56 0.50 1.14
Total revenue from operations (A) 34.65 58.18 161.64 92.83 191.11 222.04
0.15
Other Income IBI
Total Income (A+Bl 34.65 58.18 161-64 92.83 191.11 222.19
II Expenses
Cost of material consumed -
Purchases of stock-in-trade
Changes in inventories of finished goods, work-in-progress and (0.08) (0.07) 0.07 (0.15) 0.53
stock in trade
Employee benefits expense 6.53 6.14 9.23 12.67 18.46 40.06
Finance Costs
Depreciation, depletion and amortisation expense 0.06 0.06 0.07 0.12 0.13 0.25
Fees and commission expense
Net loss on fair value changes
Net loss on decognition of financial instruments under amortised
cost
Impairment of financial Instruments
Other expenses 3.95 6.36 2.92 10.31 8.51 14.93
Total Expenses 10.46 12.49 12.29 22.95 27.10 55.77
Ill Profit before exceotlonal items and tax 11-111 24.19 45.69 149.35 69.88 164.01 166.42
VIV E Px roce fip t t bio en fa ol r eIt e tm axs (Ill-IV) 24.19 45.69 149.35 69.88 164.01 166.42
VI T (a 1x ) Cex up rre en ns te ts a x (Including prior year tax) 9.87 7.03 36.49 16.89 36.70 22.41
(2) Deferred tax 0.71 0.71 0.80 1.42 1.29 0.97
VII Profit /(Loss) for the period (V-VI) 13.61 37.95 112.06 51.57 126.02 143.04
VIII O (At )h (e 1)r ItC eo mm sp tr he ah te wns ili lv ne o I tn c bo e m ree c laissified to profit or loss (180.69) (461.88) (1,697.39) (642.57) 1,259.33 2,273.77
(II) Income tax relating to items that will not be reclaissified to 25.84 66.05 242.73 91.89 (173.49) (318.56)
profit or loss
(B) (I) Items that will be reclaissified to profit or loss
(II) Income tax relating to items that will be reclaissified to profit
or loss Other Comprehensive Income (154.85) (395.83) (1,45
[Showing first 8,000 characters — download PDF for full document]